NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier
Filed with Euronext · · 2 pages · French
Watch Nanobiotix's latest callNanobiotix (Euronext:NANO) Q4 2025 Earnings Call · Replay · Apr 1Read the transcript of Nanobiotix (Euronext:NANO) Q4 2025 Earnings CallEarlier from Nanobiotix
- NANOBIOTIX Provides First Half 2026 Operational and Financial Update
- NANOBIOTIX fait le point sur ses activités et ses résultats financiers du premier semestre 2026
- NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
- NANOBIOTIX annonce les résultats complets de la phase 1 pour JNJ-1900 (NBTXR3) dans le cancer du poumon non à petites cellules inopérable et récurrent
- NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Later from Nanobiotix
- NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer
- Voting Rights and Shares Capital of the Company
- NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
Follow Nanobiotix into a list and get an email when it puts out news.
Follow Nanobiotix